Celator Pharmaceuticals
Latest round
- Series D
Last raised
- Dec 2011
Total raised
- $97M
Investors
- 8
About Celator Pharmaceuticals
Celator Pharmaceuticals, Inc. specializes in cancer treatment development. The company was founded in 2000 and is headquartered in Princeton, US.25 per share.Celator Pharmaceuticals develops innovative medicines aimed at improving cancer treatment outcomes.Celator Pharmaceuticals aims to expand its product pipeline, focusing on new cancer therapies that leverage its proprietary delivery technology. The company intends to enter new markets in Europe and Asia by 2025, utilizing funds from its recent acquisition to bolster R&D initiatives. The acquisition by Jazz Pharmaceuticals is expected to facilitate access to broader distribution channels and resources, enhancing Celator's growth potential.
Who invested in Celator Pharmaceuticals
8 investors across 6 rounds
See all investors in Celator Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celator Pharmaceuticals
Who invested in Celator Pharmaceuticals?
Celator Pharmaceuticals has 8 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celator Pharmaceuticals raised?
Celator Pharmaceuticals has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Celator Pharmaceuticals last raise money?
Celator Pharmaceuticals's most recent round on record is a Series D, in Dec 2011.
What does Celator Pharmaceuticals do?
Celator Pharmaceuticals is a biotechnology company.
Where is Celator Pharmaceuticals headquartered?
Celator Pharmaceuticals is headquartered in Princeton, US.
Which VCs invest in companies like Celator Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celator Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Celator Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.